Pharmaceutical industry shows progress with demand-driven model; more work to be done

By adopting B2B technologies such as EDI, the pharmaceutical industry is making significant progress toward enabling a demand-driven model. In many cases, inventory has decreased both at the manufacturer and wholesale levels. “Manufacturers no longer find themselves out of stock because a wholesaler has ordered too much, so they are able to manage production more effectively, as well as ...